Preprint · OA
via OpenAlex
Novel anticancer therapeutics targeting telomerase
Cancer Treatment Reviews · 2012 · ▲ 314 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.ctrv.2012.06.007
- Canonical
- link ↗
- Fetched
- 2026-06-22 MST
Cite this
APA
Ruden, M., & Puri, N. (2012). Novel anticancer therapeutics targeting telomerase. <em>Cancer Treatment Reviews</em>. https://doi.org/10.1016/j.ctrv.2012.06.007
Vancouver
Ruden M, Puri N. Novel anticancer therapeutics targeting telomerase. Cancer Treatment Reviews. 2012. doi:10.1016/j.ctrv.2012.06.007.
BibTeX
@unpublished{maria2012Novela,
title = {Novel anticancer therapeutics targeting telomerase},
author = {Maria Ruden and Neelu Puri},
journal = {Cancer Treatment Reviews},
year = {2012},
doi = {10.1016/j.ctrv.2012.06.007},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
International Journal of Molecular Sciences 2019
Open access · CC-BY
Telomerase-Targeted Cancer Immunotherapy
Current Biology 2000
Open access · OA
The telomerase reverse transcriptase is limiting and necessary for telomerase function in vivo
Nature Reviews Molecular Cell Biology 2024
Preprint · OA
Regulation of and challenges in targeting NAD+ metabolism
The EMBO Journal 2000
Open access · OA
Template definition by Tetrahymena telomerase reverse transcriptase
Oncogene 2002
Preprint · OA
Regulation of the human telomerase reverse transcriptase gene
Human Pathology 1998
Citation only